Bridgefront Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,631
Closed -$1.32M 713
2024
Q3
$1.32M Buy
+11,631
New +$1.38M 0.51% 24
2021
Q3
Sell
-14,221
Closed -$1.11M 558
2021
Q2
$1.11M Buy
+14,221
New +$1.06M 0.42% 36
2021
Q1
Sell
-9,198
Closed -$718K 828
2020
Q4
$718K Buy
+9,198
New +$703K 0.25% 117

Other funds holding MRK

Bridgefront Capital's MRK Position: Q4 2024 in Review

Bridgefront Capital sold out of Merck (MRK) in Q4 2024, closing a stake of 11,631 shares — an estimated $1.32M sold.

Bridgefront Capital first reported a position in MRK in Q4 2020 and held it in 3 quarters. The position peaked at $1.32M in Q3 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Bridgefront Capital reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Bridgefront Capital sold 11,631 Merck shares in Q4 2024, an estimated $1.32M.
  • Bridgefront Capital first reported a position in Merck in Q4 2020 and held it in 3 quarters.
  • Bridgefront Capital's Merck position peaked at $1.32M in Q3 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Bridgefront Capital's 13F filing for Q4 2024, filed 14 Feb 2025.